WPD Pharma Completed the Acquisition of Two Pancreatic Cancer Drug Candidates
WPD Pharmaceuticals Inc., a clinical stage pharmaceutical company, provides this update on the completed acquisition of exclusive sublicenses for two drug candidates from Moleculin…
Read More...
Read More...
